Incyte Corporation
INCY
$105.98
$0.780.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.37B | 1.22B | 1.05B | 1.18B | 1.14B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.37B | 1.22B | 1.05B | 1.18B | 1.14B |
| Cost of Revenue | 605.59M | 573.68M | 473.77M | 393.22M | 659.17M |
| Gross Profit | 760.40M | 641.85M | 579.13M | 785.48M | 478.70M |
| SG&A Expenses | 328.29M | 330.26M | 324.97M | 325.50M | 308.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 933.87M | 903.94M | 835.44M | 880.02M | 967.64M |
| Operating Income | 432.11M | 311.59M | 217.46M | 298.68M | 170.23M |
| Income Before Tax | 482.31M | 558.01M | 234.19M | 313.72M | 156.52M |
| Income Tax Expenses | 58.14M | 153.01M | 75.99M | 112.51M | 50.07M |
| Earnings from Continuing Operations | 424.17M | 405.00M | 158.20M | 201.21M | 106.46M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 424.17M | 405.00M | 158.20M | 201.21M | 106.46M |
| EBIT | 432.11M | 311.59M | 217.46M | 298.68M | 170.23M |
| EBITDA | 456.13M | 334.51M | 239.83M | 325.32M | 192.75M |
| EPS Basic | 2.17 | 2.09 | 0.82 | 1.04 | 0.55 |
| Normalized Basic EPS | 1.47 | 1.10 | 0.80 | 1.04 | 0.63 |
| EPS Diluted | 2.11 | 2.04 | 0.80 | 1.02 | 0.54 |
| Normalized Diluted EPS | 1.43 | 1.08 | 0.78 | 1.01 | 0.62 |
| Average Basic Shares Outstanding | 195.67M | 194.00M | 193.71M | 193.15M | 192.63M |
| Average Diluted Shares Outstanding | 201.43M | 198.74M | 198.20M | 197.42M | 195.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |